The EU ombudsman has asked the EMA to explain redactions to clinical study reports (CSRs) for AbbVie's ($ABBV) Humira. The EMA responded quickly to the publication of ...
On 4 May 2018, the European Medicines Agency (“EMA”) published another updated version of the guidance document on pre-authorisation for users of the centralised procedure. The document contains ...
AUSTIN, Texas, April 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that the European Medicines Agency (EMA) rendered a negative “trend” vote after meeting with the Company ...
Q4 2025 Management View CEO Christopher Missling reported that Anavex remains “fully committed to bringing oral blarcamesine and oral ANAVEX 3-71 to patients” and will “continue to focus on ...
January 20, 2012 — The European Medicines Agency (EMA) is recommending suspension throughout the European Union (EU) of all medicines containing meprobamate, a key ingredient in some anxiolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback